(R)-3-(N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-L-seryl)-2,2-dimethylthiazolidine-4-carboxylic acid

Catalog No. :
ACMLGA770
CAS No. :
183958-93-2
Molecular Formula :
C28H34N2O6S
Molecular Weight :
526.66

IUPAC Name:(R)-3-(N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-L-seryl)-2,2-dimethylthiazolidine-4-carboxylic acid

(R)-3-(N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-L-seryl)-2,2-dimethylthiazolidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$363.00Login to see priceInquiryInquiry
250mg98%$708.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-3-(N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-L-seryl)-2,2-dimethylthiazolidine-4-carboxylic acid
IUPAC Name(R)-3-(N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-L-seryl)-2,2-dimethylthiazolidine-4-carboxylic acid
Molecular FormulaC28H34N2O6S
Molecular Weight526.66
SMILESCC(C)(C)OC[C@H](NC(=O)OCC1C2=CC=CC=C2C2=C1C=CC=C2)C(=O)N1[C@H](C(=O)O)CSC1(C)C
InChI KeyJQVUPZNTELGQQZ-GOTSBHOMSA-N
SynonymFMoc-Ser(tBu)-Cys(psiMe,Mepro)-OH;4-Thiazolidinecarboxylic acid, 3-[(2S)-3-(1,1-dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2-dimethyl-, (4R)-;(R)-3-(N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-L-seryl)-2,2-dimethylthiazolidine-4-carboxylic acid
CAS No.183958-93-2

Synthetic Route by SureRoute

1. ACMLGA770 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLGA770 route product structure diagram
    ACMLGA770183958-93-2
Inquiry

2. ACMLGA770 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLGA770 route product structure diagram
    ACMLGA770183958-93-2
Inquiry

Comments (0)